Left main coronary artery compression in precapillary pulmonary hypertension.

IF 2.2 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Pulmonary Circulation Pub Date : 2024-05-22 eCollection Date: 2024-04-01 DOI:10.1002/pul2.12391
Ruxandra Badea, Roxana Enache, Lucian M Predescu, Pavel Platon, Nicu Catana, Dan Deleanu, Andrei George Iosifescu, Noela Radu, Teodora Radu, Georgiana Olaru-Lego, Ioan M Coman, Bogdan A Popescu
{"title":"Left main coronary artery compression in precapillary pulmonary hypertension.","authors":"Ruxandra Badea, Roxana Enache, Lucian M Predescu, Pavel Platon, Nicu Catana, Dan Deleanu, Andrei George Iosifescu, Noela Radu, Teodora Radu, Georgiana Olaru-Lego, Ioan M Coman, Bogdan A Popescu","doi":"10.1002/pul2.12391","DOIUrl":null,"url":null,"abstract":"<p><p>Pulmonary hypertension (PH) is a progressive and invalidating condition despite available therapy. Addressing complications such as left main coronary artery compression (LMCo) due to the dilated pulmonary artery (PA) may improve symptoms and survival. Nevertheless, clear recommendations are lacking. The aim of this study is to analyze the prevalence, characteristics, predictive factors and impact of LMCo in a heterogenous precapillary PH population in a single referral center. Two hundred sixty-five adults with various etiologies of precapillary PH at catheterization were reviewed. Coronary angiography (CA) was performed for LMCo suspicion. Revascularization was performed in selected cases. Outcomes were assessed at a mean follow-up of 3.9 years. LMCo was suspected in 125 patients and confirmed in 39 (31.2%), of whom 21 (16.8%) had 50%-90% stenoses. Nine revascularizations were performed, with clinical improvement. The only periprocedural complication was a stent migration. LMCo was associated with PH etiology (p 0.003), occuring more frequently in congenital heart disease-associated PH (61.5% of all LMCo cases, 66.6% of LMCo ≥ 50%). Predictors of LMCo ≥50% were PA ≥ 37.5 mm (Sn 81%, Sp 74%) and PA-to-aorta ≥1.24 (Sn 81%, Sp 69%), with increased discrimination when considering RV end-diastolic area. LMCo ≥ 50% without revascularization presented clinical deterioration and worse survival (p 0.019). This analysis of a heterogeneous pre-capillary PH population provides LMCo prevalence estimation, predictive factors (PA size, PA-to-aorta, RV end-diastolic area and PH etiology) and long-term impact. While LMCo impact on survival is inconclusive, untreated LMCo ≥ 50% has worse prognosis. LMCo revascularization may be performed safely and with good outcomes.</p>","PeriodicalId":20927,"journal":{"name":"Pulmonary Circulation","volume":"14 2","pages":"e12391"},"PeriodicalIF":2.2000,"publicationDate":"2024-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11112051/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pulmonary Circulation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pul2.12391","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Pulmonary hypertension (PH) is a progressive and invalidating condition despite available therapy. Addressing complications such as left main coronary artery compression (LMCo) due to the dilated pulmonary artery (PA) may improve symptoms and survival. Nevertheless, clear recommendations are lacking. The aim of this study is to analyze the prevalence, characteristics, predictive factors and impact of LMCo in a heterogenous precapillary PH population in a single referral center. Two hundred sixty-five adults with various etiologies of precapillary PH at catheterization were reviewed. Coronary angiography (CA) was performed for LMCo suspicion. Revascularization was performed in selected cases. Outcomes were assessed at a mean follow-up of 3.9 years. LMCo was suspected in 125 patients and confirmed in 39 (31.2%), of whom 21 (16.8%) had 50%-90% stenoses. Nine revascularizations were performed, with clinical improvement. The only periprocedural complication was a stent migration. LMCo was associated with PH etiology (p 0.003), occuring more frequently in congenital heart disease-associated PH (61.5% of all LMCo cases, 66.6% of LMCo ≥ 50%). Predictors of LMCo ≥50% were PA ≥ 37.5 mm (Sn 81%, Sp 74%) and PA-to-aorta ≥1.24 (Sn 81%, Sp 69%), with increased discrimination when considering RV end-diastolic area. LMCo ≥ 50% without revascularization presented clinical deterioration and worse survival (p 0.019). This analysis of a heterogeneous pre-capillary PH population provides LMCo prevalence estimation, predictive factors (PA size, PA-to-aorta, RV end-diastolic area and PH etiology) and long-term impact. While LMCo impact on survival is inconclusive, untreated LMCo ≥ 50% has worse prognosis. LMCo revascularization may be performed safely and with good outcomes.

毛细血管前肺动脉高压的左冠状动脉主干受压。
肺动脉高压(PH)是一种渐进性疾病,尽管已有治疗方法,但仍会使患者丧失生命。解决肺动脉(PA)扩张导致的左主冠状动脉压迫(LMCo)等并发症可改善症状,提高存活率。然而,目前还缺乏明确的建议。本研究旨在分析一个转诊中心的异质性毛细血管前PH人群中LMCo的患病率、特征、预测因素和影响。研究人员对 265 名在接受导管检查时患有不同病因的毛细血管前 PH 的成人进行了回顾性分析。在怀疑存在 LMCo 时进行了冠状动脉造影术(CA)。对部分病例进行了血管重建术。结果在平均 3.9 年的随访中进行了评估。125 例患者被怀疑患有 LMCo,39 例(31.2%)得到确诊,其中 21 例(16.8%)血管狭窄程度在 50%-90%之间。共进行了九次血管重建手术,临床症状均有所改善。唯一的围手术期并发症是支架移位。LMCo与PH病因有关(P 0.003),在先天性心脏病相关PH中发生率更高(占所有LMCo病例的61.5%,LMCo≥50%的病例占66.6%)。LMCo≥50%的预测因子是PA≥37.5 mm(Sn 81%,Sp 74%)和PA-to-aorta≥1.24(Sn 81%,Sp 69%),当考虑到RV舒张末期面积时辨别率更高。LMCo≥50%且未进行血管重建的患者临床病情恶化,存活率降低(P 0.019)。这项对异质性毛细血管扩张前 PH 患者的分析提供了 LMCo 患病率估计、预测因素(PA 大小、PA 对主动脉、RV 舒张末期面积和 PH 病因学)和长期影响。虽然 LMCo 对生存的影响尚无定论,但未经治疗的 LMCo ≥ 50%,预后较差。LMCo 血管再通手术可以安全进行,且效果良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pulmonary Circulation
Pulmonary Circulation Medicine-Pulmonary and Respiratory Medicine
CiteScore
4.20
自引率
11.50%
发文量
153
审稿时长
15 weeks
期刊介绍: Pulmonary Circulation''s main goal is to encourage basic, translational, and clinical research by investigators, physician-scientists, and clinicans, in the hope of increasing survival rates for pulmonary hypertension and other pulmonary vascular diseases worldwide, and developing new therapeutic approaches for the diseases. Freely available online, Pulmonary Circulation allows diverse knowledge of research, techniques, and case studies to reach a wide readership of specialists in order to improve patient care and treatment outcomes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信